530 related articles for article (PubMed ID: 21592595)
1. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes.
Mabb AM; Judson MC; Zylka MJ; Philpot BD
Trends Neurosci; 2011 Jun; 34(6):293-303. PubMed ID: 21592595
[TBL] [Abstract][Full Text] [Related]
2. Abundance and localization of human UBE3A protein isoforms.
Sirois CL; Bloom JE; Fink JJ; Gorka D; Keller S; Germain ND; Levine ES; Chamberlain SJ
Hum Mol Genet; 2020 Nov; 29(18):3021-3031. PubMed ID: 32833011
[TBL] [Abstract][Full Text] [Related]
3. Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways.
Lopez SJ; Laufer BI; Beitnere U; Berg EL; Silverman JL; O'Geen H; Segal DJ; LaSalle JM
Hum Mol Genet; 2019 Nov; 28(22):3842-3852. PubMed ID: 31625566
[TBL] [Abstract][Full Text] [Related]
4. MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression.
Makedonski K; Abuhatzira L; Kaufman Y; Razin A; Shemer R
Hum Mol Genet; 2005 Apr; 14(8):1049-58. PubMed ID: 15757975
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Nociception in Angelman Syndrome Model Mice.
McCoy ES; Taylor-Blake B; Aita M; Simon JM; Philpot BD; Zylka MJ
J Neurosci; 2017 Oct; 37(42):10230-10239. PubMed ID: 28931574
[TBL] [Abstract][Full Text] [Related]
6. Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a.
Yamasaki K; Joh K; Ohta T; Masuzaki H; Ishimaru T; Mukai T; Niikawa N; Ogawa M; Wagstaff J; Kishino T
Hum Mol Genet; 2003 Apr; 12(8):837-47. PubMed ID: 12668607
[TBL] [Abstract][Full Text] [Related]
7. A bipartite boundary element restricts
Hsiao JS; Germain ND; Wilderman A; Stoddard C; Wojenski LA; Villafano GJ; Core L; Cotney J; Chamberlain SJ
Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2181-2186. PubMed ID: 30674673
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.
LaSalle JM; Reiter LT; Chamberlain SJ
Epigenomics; 2015 Oct; 7(7):1213-28. PubMed ID: 26585570
[TBL] [Abstract][Full Text] [Related]
9. Persistent neuronal Ube3a expression in the suprachiasmatic nucleus of Angelman syndrome model mice.
Jones KA; Han JE; DeBruyne JP; Philpot BD
Sci Rep; 2016 Jun; 6():28238. PubMed ID: 27306933
[TBL] [Abstract][Full Text] [Related]
10. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons.
Albrecht U; Sutcliffe JS; Cattanach BM; Beechey CV; Armstrong D; Eichele G; Beaudet AL
Nat Genet; 1997 Sep; 17(1):75-8. PubMed ID: 9288101
[TBL] [Abstract][Full Text] [Related]
11. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.
Meng L; Ward AJ; Chun S; Bennett CF; Beaudet AL; Rigo F
Nature; 2015 Feb; 518(7539):409-12. PubMed ID: 25470045
[TBL] [Abstract][Full Text] [Related]
12. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome.
Matsuura T; Sutcliffe JS; Fang P; Galjaard RJ; Jiang YH; Benton CS; Rommens JM; Beaudet AL
Nat Genet; 1997 Jan; 15(1):74-7. PubMed ID: 8988172
[TBL] [Abstract][Full Text] [Related]
13. A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome.
Geerts-Haages A; Bossuyt SNV; den Besten I; Bruggenwirth H; van der Burgt I; Yntema HG; Punt AM; Brooks A; Elgersma Y; Distel B; Valstar M
Mol Genet Genomic Med; 2020 Nov; 8(11):e1481. PubMed ID: 32889787
[TBL] [Abstract][Full Text] [Related]
14. Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model.
Meng L; Person RE; Huang W; Zhu PJ; Costa-Mattioli M; Beaudet AL
PLoS Genet; 2013; 9(12):e1004039. PubMed ID: 24385930
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
Samaco RC; Hogart A; LaSalle JM
Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
[TBL] [Abstract][Full Text] [Related]
16. Ube3a imprinting impairs circadian robustness in Angelman syndrome models.
Shi SQ; Bichell TJ; Ihrie RA; Johnson CH
Curr Biol; 2015 Mar; 25(5):537-45. PubMed ID: 25660546
[TBL] [Abstract][Full Text] [Related]
17. Mutation Update for UBE3A variants in Angelman syndrome.
Sadikovic B; Fernandes P; Zhang VW; Ward PA; Miloslavskaya I; Rhead W; Rosenbaum R; Gin R; Roa B; Fang P
Hum Mutat; 2014 Dec; 35(12):1407-17. PubMed ID: 25212744
[TBL] [Abstract][Full Text] [Related]
18. Differentiating molecular etiologies of Angelman syndrome through facial phenotyping using deep learning.
Gomez DA; Bird LM; Fleischer N; Abdul-Rahman OA
Am J Med Genet A; 2020 Sep; 182(9):2021-2026. PubMed ID: 32524756
[TBL] [Abstract][Full Text] [Related]
19. Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model.
Silva-Santos S; van Woerden GM; Bruinsma CF; Mientjes E; Jolfaei MA; Distel B; Kushner SA; Elgersma Y
J Clin Invest; 2015 May; 125(5):2069-76. PubMed ID: 25866966
[TBL] [Abstract][Full Text] [Related]
20. Novel intragenic deletions within the UBE3A gene in two unrelated patients with Angelman syndrome: case report and review of the literature.
Aguilera C; Viñas-Jornet M; Baena N; Gabau E; Fernández C; Capdevila N; Cirkovic S; Sarajlija A; Miskovic M; Radivojevic D; Ruiz A; Guitart M
BMC Med Genet; 2017 Nov; 18(1):137. PubMed ID: 29162042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
